LUGARESI, Alessandra
 Distribuzione geografica
Continente #
EU - Europa 8.370
NA - Nord America 7.531
AS - Asia 3.398
Continente sconosciuto - Info sul continente non disponibili 21
SA - Sud America 8
OC - Oceania 6
AF - Africa 5
Totale 19.339
Nazione #
US - Stati Uniti d'America 7.509
IT - Italia 2.024
UA - Ucraina 1.565
CN - Cina 1.548
IE - Irlanda 1.343
TR - Turchia 1.065
GB - Regno Unito 984
SE - Svezia 714
FR - Francia 631
SG - Singapore 462
DE - Germania 460
FI - Finlandia 322
RU - Federazione Russa 216
IN - India 198
IR - Iran 37
VN - Vietnam 34
CZ - Repubblica Ceca 21
EU - Europa 21
CA - Canada 19
BE - Belgio 18
JP - Giappone 18
IL - Israele 16
ES - Italia 12
GR - Grecia 10
PL - Polonia 10
DK - Danimarca 8
KR - Corea 8
AT - Austria 6
AU - Australia 6
BR - Brasile 6
MK - Macedonia 5
NL - Olanda 4
EG - Egitto 3
HR - Croazia 3
MX - Messico 3
RO - Romania 3
TW - Taiwan 3
BD - Bangladesh 2
CH - Svizzera 2
LU - Lussemburgo 2
RS - Serbia 2
AM - Armenia 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
HK - Hong Kong 1
HU - Ungheria 1
KH - Cambogia 1
LV - Lettonia 1
ME - Montenegro 1
MM - Myanmar 1
MZ - Mozambico 1
NO - Norvegia 1
PH - Filippine 1
TH - Thailandia 1
UY - Uruguay 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 19.339
Città #
Jacksonville 1.788
Chandler 1.494
Dublin 1.332
Southend 798
Princeton 618
Izmir 600
Nanjing 462
Singapore 378
Wilmington 349
Cambridge 303
Beijing 250
Ashburn 202
Altamura 200
Nanchang 182
Dearborn 157
Ann Arbor 150
Woodbridge 130
Boardman 97
Shenyang 93
Jiaxing 89
Milan 85
New York 84
Hebei 81
Chieti 75
Kunming 73
Rome 72
Tianjin 70
Norwalk 64
Santa Clara 60
Houston 59
Grevenbroich 46
Hangzhou 45
Changsha 42
Los Angeles 40
San Mateo 39
Torino 39
Dong Ket 33
Washington 33
Bologna 30
Leawood 30
Ardabil 29
Naples 28
Florence 27
Orange 26
Augusta 25
Moscow 25
Helsinki 24
Jinan 24
Turin 23
Changchun 20
Lanzhou 20
Bari 19
Brno 18
Verona 18
Guangzhou 16
Cedar Knolls 15
Monmouth Junction 15
Pisa 15
Campobasso 14
Ningbo 14
Brussels 13
Catania 13
Catanzaro 12
Genoa 12
Genova 12
Hanover 12
Seattle 12
Zhengzhou 12
Falls Church 11
Palermo 11
Taizhou 11
Auburn Hills 10
Munich 10
Casièr 9
Poggio Picenze 9
Tappahannock 9
Toronto 9
London 8
Venezia 8
Andover 7
Hefei 7
Massa E Cozzile 7
Mumbai 7
Napoli 7
Parma 7
Pescara 7
Reggio Calabria 7
Teramo 7
Cagliari 6
Cazzago San Martino 6
Codogno 6
Montréal 6
Padova 6
San Vito Chietino 6
Edinburgh 5
Perugia 5
Piacenza 5
Portici 5
Shanghai 5
Trieste 5
Totale 11.519
Nome #
La risposta simpatica cutanea: basi neurofisiologiche, valori normativi, applicazioni cliniche 1.226
The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): normative values with gender, age and education corrections in the Italian population 206
Ruolo degli anticorpi anti-gangliosidi nelle neuropatie e nelle malattie del motoneurone 186
Un caso di mieloneuropatia da HTLV- I in Italia 180
Miastenia gravis "distale" e neuronopatia sensitiva simulanti una neuropatia sensori-motoria 168
Polineuropatia assonale cronica progressiva sensibile al trattamento steroideo: una neuropatia assonale primitiva o una variante della poliradicoloneuropatia cronica ingiammatoria demielinizzante? 159
An integrated metabolomics approach for the research of new cerebrospinal fluid biomarkers of multiple sclerosis 138
IL 13 in multiple sclerosis 117
Anti-GD1a Antibodies from Acute Motor Axonal Neuropathy Patients Selectively Bind to Ranvier Nodes of Motor Nerve Fibers 115
Studio comparativo multicentrico sulla misurazione degli anticorpi IgM ANTI-GM1 nel siero di pazienti con neuropatia motoria multifocale e sclerosi laterale amiotrofica 103
The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Normative Values With Gender, Age And Education Corrections In The Italian Population (P5.015) 101
Cleavage of cystatin C is not associated with multiple sclerosis 101
Utilità dell'ecobiometria del nervo ottico nella diagnosi e nel follow-up della neurite ottica retrobulbare 100
Amplifications of multiple regions of the HTLV-I genome from DNA of an Italian spastic paraparesis patient but not from DNA of multiple sclerosis patients. 95
Utilità della tecnica destir (RM) nella diagnosi di neurite ottica retrobulbare 93
La funzione soppressoria è ridotta nella polineuropatia demielinizzante cronica infiammatoria (CIDP) 93
The brief international cognitive assessment for multiple sclerosis (bicams): normative values in the Italian population. 91
Lipidomic investigations for the characterization of circulating serum lipids in multiple sclerosis 91
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP) ASSOCIATED WITH MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS 90
Metabolomics analysis of cerebrospinal fluid reveals a distintive biochemical alteration associated with multiple sclerosis. 89
A lipidomic investigation for the caracterisation of CSF lipid profile in patients with multiple sclerosis 88
F response in vascular and degenerative upper motor neuron lesions 87
Transdermal scopolamine cycloplegia in juvenile diabetes 87
The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry. 87
The Multiple Sclerosis Knowledge Questionnaire: a self administered instrument for recently diagnosed patients 86
Anti-GD1a antibodies from an acute motor axonal neuropathy patient selectively bind to motor nerve fiber nodes of Ranvier 85
Adhesion molecule expression in sural nerve of chronic inflammatory demyelinating polineuropaty 84
Independent component analysis for the extraction of reliable protein signal profiles from MALDI-TOF mass spectra 84
A computational platform for MALDI-TOF mass spectrometry data: Application to serum and plasma samples 84
TLC-MALDI-Imaging approach for lipidomics studies in cerebrospinal fluid reveals low levels of sphingomyelin in multiple sclerosis patients 84
Recurrent cranial nerve palsies, midbrain infarction and hydrocephalus due to megadolichobasilar artery 83
Effetti sinergici della terapia con interferone-beta sulla attivazione, adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante/remittente 83
Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei 82
Increasing age at disability milestones among MS patients in the MSBase Registry 82
The Chieti experience with Interferon B1b (IFNB1b) during the first 2 years: side effects. 80
Prednisone and plasma exchange improve suppressor cell function in chronic inflammatory demyelinating polyneuropathy. 80
Effect of TNF intraneural injection into the rat sciatic nerve 79
Anti-ganglioside antibodies in the Guillain-Barré syndrome (GBS): a case control study 79
Chemokine production by mononuclear cells from relapsing-remitting multiple sclerosis (RR-MS) patients 79
Rantes Levels and mRNA Expression in Relapsing-Remitting Multiple Sclerosis (RR-MS): Effect of interferon Beta 1b (IFNBeta 1b) Treatment 78
Chemokines are Modulated by Interferon beta 1B (IFNT-Beta IB) in Relapsing-Remitting Multiple Sclerosis (RR-MS) 77
Dysimmune demyelinating polyneuropathies: expression of adhesion molecules in sural nerves and changes in cellular immunity (suppressor cell function and cytokine mRNA expression) induced by treatment (progetto presentato a Telethon) 77
Anti-glycolipid and anti-tubulin antibodies in chronic inflammatory demyelinating polyneuropathy 77
Addressing the need for increased adherence to multiple sclerosis therapy: can delivery technology enhance patient motivation? 77
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone 77
Convulsive status epilepticus due to new encephalic demyelinating lesions in multiple sclerosis 77
Hand dystonia due to cervical lesions 77
Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS. 77
Neurite ottica: relazione tra perimetria, PEV e RMN 76
Chronic inflammatory demyelinating polyneuropathy in diabetes 76
Binding of Anti GD1 a Antibodies in Peripheral Nerve. Abstracts of the 4th Meeting of the Italian Peripheral Nerve Study Group - Chieti, March 26-27 1999 76
May electrophysiology differentiate chronic inflammatory demyelinating polyneuropathy (CIDP) and polineuropathy with anti- SGPG antibodies? 76
Acute motor conduction block neuropathy Another Guillain-Barré syndrome variant. 76
Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis 75
Neurite ottica retrobulbare: studio biometrico del nervo ottico 75
The Chieti Experience with interferon B1b (IFNB1b) during the first 2 years: Efficacy 75
Rantes and MCP-1 Secretion by Mononuclear Cells of Patients with Nultiple Sclerosis 75
Serum soluble adhesion molecules and proinflammatory cytokines are not increased in chronic inflammatory demyelinating polyneuropathy 74
TheND1 gene of complex I is a mutational hot spot for Leber’s hereditary optic neuropathy 74
Real-life impact of early interferon beta therapy in relapsing multiple sclerosis 74
Protein profiling of Guillain-Barrè Syndrome cerebrospinal fluid by two dimensional electrophoresis and mass spectrometry. 74
Patterns in patients’expression of emotions and neurologists’ response. 74
Anti-glicolipid antibodies in chronic inflammatory demyelinating polyneuropathy (CIDP) 73
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis 73
Plasma exchange and prednisone improve suppressor cell function in dysimmune neuropathies 72
Lack of vegetative and endocrine circadian rhythms in fatal familial thalamic degeneration 72
Extrapyramidal syndrome and depression induced by flunarizine 72
Effect of the disclosure of MS diagnosis on anxiety, mood and quality of life of patients: a prospective study 72
"Minimal" chronic inflammatory demyelinating polyneuropathy 71
MCP-1 expression and secretion in adherent monocyte cultures from multiple sclerosis patients treated with interferon beta-1b 71
Acute motor axonal neuropathy with high titer IgG and IgA anti-GD1a antibodies following Campylobacter enteritis 71
OXIDATIVE MODIFICATIONS OF CEREBRAL TRANSTHYRETIN ARE ASSOCIATED WITH MULTIPLE SCLEROSIS 71
Interferon beta normalizes suppressor cell function in dysimmune neuropathies. 71
Development of methods for lipid extraction from CSF and application of mass spectometry techniques for the characterization of the lipid profile and neurosteroids levels in MS patients 70
Demyelinating motor Guillain-Barré syndrome following Rubella 70
Aspetti immunologici delle poliradicoloneuriti croniche 69
Comparison of Switch to Fingolimod or Interferon Beta/Glatiramer Acetate in Active Multiple Sclerosis 69
Shared T Cell Receptor Usage of Cerebrospinal Fluid Cells in Familial Multiple Sclerosis da: X° National A.I.N.I. Congress Association Italiana Neuroimmunologia - Florence, Italy, November 15/16,1999 69
Minimal and Ssymptomatic Chronic inflammatory demyelinating Polyneuropathy. da:Abstracts of the 4th Meeting of the Italian Peripheral Nerve Study Group- Chieti Marzo 26-27-1999 69
Chemokine secretion by mononuclear cells of patients with multiple sclerosis (MS) 69
Chronic inflammatory demyelinating polyneuropathy in diabetes mellitus 69
Brain tissue loss occurs after suppression of enhancement in patients with multiple scerosis treated with autologous haematopoietic stem cell transplantation. 69
Can electrophysiology differentiate polyneuropathy with anti-MAG/SGPG antibodies from chronic inflammatory demyelinating polyneuropathy? 69
Breastfeeding is not related to postpartum relapses in multiple sclerosis. 69
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome. 69
Cognitive dysfunction in patients with relapsing-remitting Multiple Sclerosis 69
Autoimmunity and interferon beta1B 68
Interferon beta1b: the Chieti experience 68
Frequency and risk factors of mitoxantrone-induced amenorrhea in multiple sclerosis: the FEMIMS study 68
76.Distal myasthenia gravis and sensory neuronopathy with anti-50 kDa antibody mimicking sensory-motor neuropathy. 68
Patient adherence to and tolerability of self-administered interferon beta-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study 68
Anti-JCV serostatus, index value and clinical features in patients affected by multiple sclerosis. 68
Natalizumab treatment in multiple sclerosis patients: a multicenter experience in clinical practice in Italy. 68
An information aid for newly diagnosed multiple sclerosis patients improves disease knowledge and satisfaction with care. 68
Livelli sierici e liquorali di IL13 nella Sclerosi Multipla 67
Expression of adhesion molecules in sural nerve of chronic inflammatory demyelinating polyneuropathy (CIDP) 67
Effetti sinergici della terapia con interferone-beta sulla attivazione. Adesione ed apoptosi linfocitaria nella sclerosi multipla esacerbante /remittente. (C22) 67
Sclerosi multipla: meccanismi patogenetici alla base della demielinizzazione 67
A comparison of the Brief International Cognitive Assessment for Multiple Sclerosis and a brief repeatable battery in multiple sclerosis patients. 67
Development and validation of a patient self-assessed questionnaire on satisfaction with communication of the multiple sclerosis diagnosis. 67
Totale 9.503
Categoria #
all - tutte 66.864
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.864


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.298 0 312 18 147 217 186 394 362 49 193 393 27
2020/20211.941 318 10 313 18 154 389 19 14 177 219 183 127
2021/20221.206 13 21 19 194 63 35 42 100 94 27 198 400
2022/20234.240 378 509 193 501 419 855 291 306 492 55 131 110
2023/20241.880 152 105 112 52 85 549 467 75 24 43 37 179
2024/2025830 343 487 0 0 0 0 0 0 0 0 0 0
Totale 19.570